Proposed Investment

Proposed Investment /
use of funds

Go-AI is a company based in Melbourne, Victoria.
Go-AI’s business is dedicated to applying proprietary nano medical engineering technologies to early detect and treat together with immunotherapy drugs for combination therapy of cancer diseases.
Go-AI has placed 600,000 new shares at A$1.00 per share (First tranche Offer) to raise A$600,000 to finance Go-AI and Nanotherapy Plus business development, and overheads. Refer to next slide: Capital Management Plan.
This first placement represents about 0.5% of expanded issued capital of 100.6 million shares. (Link: Share placement application)

Capital Management Plan*/ Use of funds

First tranche Offer: 600,000 shares at A$1 per share. (Closed)
-Covered operating overheads and provisional patent application.
Second tranche Offer: 500,000 shares at A$2 per share.
-For completion of invitro studies on human cancer cell lines for multiple cancer types, preclinical animal studies, phase 1 clinical trial, and additional patent filing legal costs.
Third tranche Offer: pre IPO 2 million shares at A$3 per share.
-For completion of phase 2 clinical trials, additional patent filing legal costs.
IPO at A$10 per share issuing an additional 2 million new shares at A$10 per share.
-For completion of IPO professional work and meeting requirements of stock exchange listing.
Projected total issued capital at IPO will be 105 million shares.
*Go-AI Pty Ltd reserves the absolute right to change its Capital Management Plan as to price, quantity and timing of securities to be offered prior to each tranche of the Offer.